XML 39 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Incentive Plans
3 Months Ended
Mar. 31, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Incentive Plans
14. STOCK-BASED INCENTIVE PLANS
We are externally managed by our Manager and do not currently have any employees. However, as of March 31, 2021, our Manager, certain individuals employed by an affiliate of our Manager, and certain members of our board of directors were compensated, in part, through our issuance of stock-based instruments.
We had stock-based incentive awards outstanding under nine benefit plans as of March 31, 2021. Seven of such benefit plans have expired and no new awards may be issued under them. Under our two current benefit plans, a maximum of 5,000,000 shares of our class A common stock may be issued to our Manager, our directors and officers, and certain employees of affiliates of our Manager. As of March 31, 2021, there were 2,001,125 shares available under our current benefit plans.
The following table details the movement in our outstanding shares of restricted class A common stock and the weighted-average grant date fair value per share:
 
    
Restricted Class A
Common Stock
    
Weighted-Average

Grant Date Fair
Value Per Share
 
Balance as of December 31, 2020
     1,627,890      $ 33.14  
Granted
     263,809        26.16  
Vested
     (170,942      35.21  
Forfeited
     (13,273      32.61  
    
 
 
    
 
 
 
Balance as of March 31, 2021
     1,707,484      $ 31.86  
    
 
 
    
 
 
 
These shares generally vest in installments over a three-year period, pursuant to the terms of the respective award agreements and the terms of our current benefit plans. The 1,707,484 shares of restricted class A common stock outstanding as of March 31, 2021 will vest as follows: 793,646 shares will vest in 2021; 632,999 shares will vest in 2022; and 280,839 shares will vest in 2023. As of March 31, 2021, total unrecognized compensation cost relating to unvested share-based compensation arrangements was $49.9 million based on the grant date fair value of shares granted. This cost is expected to be recognized over a weighted-average period of 1.1 years from March 31, 2021.